(Press-News.org) (New York – June 9, 2014) -- A protein may be the key to maintaining the health of aging blood stem cells, according to work by researchers at the Icahn School of Medicine at Mount Sinai recently published online in Stem Cell Reports. Human adults keep stem cell pools on hand in key tissues, including the blood. These stem cells can become replacement cells for those lost to wear and tear. But as the blood stem cells age, their ability to regenerate blood declines, potentially contributing to anemia and the risk of cancers like acute myeloid leukemia and immune deficiency. Whether this age-related decline in stem cell health is at the root of overall aging is unclear.
The new Mount Sinai study reveals how loss of a protein called Sirtuin1 (SIRT1) affects the ability of blood stem cells to regenerate normally, at least in mouse models of human disease. This study has shown that young blood stem cells that lack SIRT1 behave like old ones. With use of advanced mouse models, she and her team found that blood stem cells without adequate SIRT1 resembled aged and defective stem cells, which are thought to be linked to development of malignancies.
"Our data shows that SIRT1 is a protein that is required to maintain the health of blood stem cells and supports the possibility that reduced function of this protein with age may compromise healthy aging," says Saghi Ghaffari, MD, PhD, Associate Professor of Developmental and Regenerative Biology at Mount Sinai's Black Family Stem Cell Institute, Icahn School of Medicine. "Further studies in the laboratory could improve are understanding between aging stem cells and disease."
Next for the team, which includes Pauline Rimmelé, PhD, is to investigate whether or not increasing SIRT1 levels in blood stem cells protects them from unhealthy aging or rejuvenates old blood stem cells. The investigators also plan to look at whether SIRT1 therapy could treat diseases already linked to aging, faulty blood stem cells.
They also believe that SIRT1 might be important to maintaining the health of other types of stem cells in the body, which may be linked to overall aging.
The notion that SIRT1 is a powerful regulator of aging has been highly debated, but its connection to the health of blood stem cells "is now clear," says Dr. Ghaffari. "Identifying regulators of stem cell aging is of major significance for public health because of their potential power to promote healthy aging and provide targets to combat diseases of aging," Dr. Ghaffari says.
INFORMATION:
Researchers from Harvard Medical School and Children's Hospital in Boston participated in the study.
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.
For more information, visit http://www.mountsinai.org, or find Mount Sinai on Facebook, Twitter and YouTube.
Mount Sinai researchers identify protein that keeps blood stem cells healthy as they age
2014-06-09
ELSE PRESS RELEASES FROM THIS DATE:
Viewing plant cells in 3-D (no glasses required)
2014-06-09
VIDEO:
This shows 3-D ortho-rotation of leaf mesophyll cells. Micrographs were collected by milling fixed tissue accompanied by SEM imaging using FIB-SEM. The complete videos published with the article are available...
Click here for more information.
Plant cells are beginning to look a lot different to Dr. A. Bruce Cahoon and his colleagues at Middle Tennessee State University (MTSU). They've adopted a new approach that combines the precision of an ion beam with the imaging ...
Needle biopsy underused in breast cancer diagnosis, negatively impacting diagnosis and care
2014-06-09
Needle biopsy, the standard of care radiological procedure for diagnosing breast cancer, is underused with too many patients undergoing the more invasive, excisional biopsy to detect their disease, according to research from The University of Texas MD Anderson Cancer Center.
The study, published in the Journal of Clinical Oncology, also finds that patients are often influenced by surgeons to undergo the unnecessary surgery -- a decision that's costly and can negatively impact their diagnosis and treatment.
A needle biopsy is a non-surgical procedure typically performed ...
Women and health-care providers differ on what matters most about contraception
2014-06-09
LEBANON, NH – When women are choosing a contraceptive, health care providers should be aware that the things they want to discuss may differ from what women want to hear, according to a survey published in the recent issue of the journal Contraception.
Most of the information women receive about contraceptives focuses heavily on the effectiveness in preventing pregnancy, but this information was ranked fifth in importance by women, according to the study conducted by researchers at Dartmouth College.
The researchers conducted an online survey of 417 women, aged 15-45, ...
JCI online ahead of print contents for June 9, 2014
2014-06-09
Clinical trial evaluates ex vivo cultured cord blood
Umbilical cord blood (UCB) is a rich source of hematopoietic stem and progenitor cells (HSPCs) that can be used for bone marrow transplantation; however, UCB transplantation is hampered by low numbers of HSPCs per donation, which delays engraftment and immune reconstitution. In this issue of the Journal of Clinical Investigation, Mitchell Horwitz and colleagues at Duke University Medical Center conducted a phase I clinical trial to test the long term engraftment capability of UCB HSPCs that were expanded ex vivo for ...
Newly identified B-cell selection process adds to understanding of antibody diversity
2014-06-09
BOSTON – As elite soldiers of the body's immune response, B cells serve as a vast standing army ready to recognize and destroy invading antigens, including infections and cancer cells. To do so, each new B cell comes equipped with its own highly specialized weapon, a unique antibody protein that selectively binds to specific parts of the antigen. The key to this specialization is the antigen-binding region that tailors each B cell to a particular antigen, determining whether B cells survive boot camp and are selected for maturation and survival, or wash out and die.
Now, ...
Faster, higher, stronger: A protein that enables powerful initial immune response
2014-06-09
Your first response to an infectious agent or antigen ordinarily takes about a week, and is relatively weak. However, if your immune system encounters that antigen a second time, the so-called memory response is rapid, powerful, and very effective.
Now, a team of researchers at The Wistar Institute offers evidence that a protein, called Foxp1, is a key component of these antibody responses. Manipulating this protein's activity, they say, could provide a useful pathway to boosting antibody responses to treat infectious diseases, for example, or suppressing them to treat ...
The Academy of Radiology Research featured in Nature Biotechnology journal
2014-06-09
The Academy of Radiology Research reported in the current issue of Nature Biotechnology (Volume 32, Issue 6) that patent output from the National Institutes of Health (NIH) is vital to understanding which various areas of science are contributing most to America's innovation economy. The report, "Patents as Proxies: NIH Hubs of Innovation," confirms an increased economic value of NIH patents as compared to private sector patents, as well as meaningful differences in the rate and quality of invention across different research and development (R&D) investments.
"The Academy ...
NOAA scientists find mosquito control pesticide low risk to juvenile oysters, hard clams
2014-06-09
Four of the most common mosquito pesticides used along the east and Gulf coasts show little risk to juvenile hard clams and oysters, according to a NOAA study.
However, the study, published in the on-line journal Archives of Environmental Contamination and Toxicology, also determined that lower oxygen levels in the water, known as hypoxia, and increased acidification actually increased how toxic some of the pesticides were. Such climate variables should be considered when using these pesticides in the coastal zone, the study concluded.
"What we found is that larval oysters ...
Antiviral therapy may prevent liver cancer in hepatitis B patients
2014-06-09
DETROIT – Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
That was the finding of a study published in the May issue of Clinical Gastroenterology and Hepatology. Investigators from Henry Ford Health System in Detroit, Geisinger Health System in Danville, Pa., and Kaiser Permanente in Honolulu, Hawaii and Portland, Ore. participated in the study, along with investigators from the Centers for Disease Control and Prevention in Atlanta. ...
How much fertilizer is too much for the climate?
2014-06-09
EAST LANSING, Mich. — Helping farmers around the globe apply more-precise amounts of nitrogen-based fertilizer can help combat climate change.
In a new study published in this week's Proceedings of the National Academy of Sciences, Michigan State University researchers provide an improved prediction of nitrogen fertilizer's contribution to greenhouse gas emissions from agricultural fields.
The study uses data from around the world to show that emissions of nitrous oxide, a greenhouse gas produced in the soil following nitrogen addition, rise faster than previously expected ...